HEMAVATHY HARIKRISHNAN

Ph.D. Molecular biologist with 12+ years of research experience specializing in gene therapy, viral vector biology, and quantitative analytical method development. Deep expertise in molecular biology techniques applied to in vitro and in vivo models, gene editing, and disease characterization. Published researcher with a proven ability to independently design and execute complex experiments, generate high-quality data, and communicate findings clearly across multidisciplinary teams.

• Harikrishnan H et al. CRISPR/Cas9-mediated homology-directed repair rescues induced bone marrow failure in Fanconi anemia (FANCC) mice. Molecular Therapy Nucleic Acids, In Press, 2026.
• Takita S., Harikrishnan H. et al. Transcriptional downregulation of rhodopsin is associated with desensitization of rods to light-induced damage in retinitis pigmentosa. Human Molecular Genetics, 2025.
• (Full list available upon request)

• Authorized to work in the United States; — no employer sponsorship required
• Effective communicator of complex technical data to multidisciplinary project teams and stakeholders
• Proven ability to manage multiple concurrent priorities in fast-paced, collaborative research environments